EU News - February 1
Discover new INTERREG and ERANET/JPI calls and the launch of a EU support concept for VUB researchers. Read the newsletter here.
What makes the Flemish biotech so successful?
The recent news about the takeover bids on VUB spin-off Ablynx and start-up Aelin Therapeutics who raised €27 million capital, makes us wonder why international investors ace on Flemish start-ups? Els…
FFM Call for oncology projects 2018
This call of the Fournier-Majoie Foundation is open to Academic or Non-academic Entrepreneurs, Start-up companies looking for Pre-seed, Seed financing, to accelerate their development oncology projects.
VUB spin-off Zensor wins Innoviris Rise Award
More fuel for the future of integrity management The world of large investment projects will change radically in the coming years. As Brussels-based Scale-up and located in the incubator ICAB, Zensor…
Sanofi takes over Ablynx for 3,9 billion euro
Sanofi has seen off interest from rival Novo Nordisk to acquire Belgian biopharma Ablynx, agreeing to buy the company for €3.9bn in its second major acquisition this month. Read the articles in De…
EU News - January 25
New H2020 calls are open in Energy, Innovation and Fuel Cell Hydrogen. The EU-R&D team organizes a workshop on ERC in April. More info here.
EU News - January 18
Today the H2020-MSCA-ITN-2018 call was successfully closed with 46 ITN proposals submitted of which 12 proposals as coordinator. More info here.
Green Energy Park project Zellik launched!
On January 18, stakeholders gathered in the U-Residence at our campus in Etterbeek for the successful launch of the Green Energy Park Zellik project. This CO2 neutral smart grid will include solar and…
Interview with CEO of Collibra Felix Van de Maele
Since this week VUB spin-off Collibra has received investments of more than 100 million dollars from large American funders, such as Iconiq Capital. In an interview in De Tijd CEO Felix Van de Maele talks…
PharmaFluidics completed €7.3 million capital increase
VUB spin-off PharmaFluidics raises €7.3 million to expand commercialization of novel micro-chip device for biomarker, diagnostics and drug development applications. The company will focus on intensifying…